Publications by authors named "Hanne Puntervoll"

Claim this Profile
[
[Cervical sample-taking in the primary health service].
Priyanthi Borgen Gjerde, Mette Christophersen Tollånes, Ameli Tropé, Maj Liv Eide, Marianne Natvik, Hanne Eknes Puntervoll

Tidsskr Nor Laegeforen· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Throat infections and use of streptococcal antigen test and antibiotic treatment in general practice; a web-based survey.
Hanne Puntervoll, Pål Jenum, Sigurd Høye, Mette Tollånes

Scand J Prim Health Care· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
Rakel Brendsdal Forthun, Randi Hovland, Cornelia Schuster, Hanne Puntervoll, Hans Petter Brodal

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.
Emilia Hugdahl, May Britt Kalvenes, Hanne E Puntervoll, Rita G Ladstein, Lars A Akslen

Br J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequencies of KIT and GNAQ mutations in acral melanoma.
Hanne Eknes Puntervoll, Anders Molven, Lars Andreas Akslen

J Cutan Pathol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of somatic BRAF mutations in melanocytic lesions from patients in a CDK4 melanoma family.
Hanne E Puntervoll, Anders Molven, Lars A Akslen

Pigment Cell Melanoma Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril

J Med Genet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
Cornelia Schuster, Hans P Eikesdal, Hanne Puntervoll, Jürgen Geisler, Stephanie Geisler

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.
Ingeborg M Bachmann, Hanne E Puntervoll, Arie P Otte, Lars A Akslen

Mod Pathol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
Lars A Akslen, Hanne Puntervoll, Ingeborg M Bachmann, Oddbjørn Straume, Edda Vuhahula

Melanoma Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer.
Ole Johan Halvorsen, Kari Rostad, Anne Margrete Øyan, Hanne Puntervoll, Trond Hellem Bø

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Ingeborg M Bachmann, Oddbjørn Straume, Hanne E Puntervoll, May Britt Kalvenes, Lars A Akslen

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis